Changes in serial dexamethasone suppression tests among unipolar depressive receiving electroconvulsive treatment

Area of Science:

• Neuroscience
• Psychiatry
• Clinical Medicine

Background:

• Abnormal dexamethasone suppression tests (DSTs) are linked to endogenous depression.
• DST normalization correlates with successful treatment outcomes.
• The utility of serial DSTs for monitoring treatment and predicting outcomes requires further investigation.

Purpose of the Study:

• To assess if serial DSTs can biologically monitor clinical response in major depressive disorder patients undergoing electroconvulsive therapy (ECT).
• To determine the timing of DST normalization during ECT.
• To investigate whether early DST normalization predicts treatment outcomes.

Main Methods:

• Six inpatients with endogenous major depressive disorder and abnormal DSTs underwent serial DSTs during and after ECT.
• Clinical improvement was assessed weekly using the Hamilton Rating Scale.
• DST plasma cortisol levels were measured serially.

Main Results:

• Five out of six patients with abnormal DSTs normalized their tests and showed significant clinical improvement.
• One patient did not normalize the DST and had a poor outcome.
• DST normalization occurred between the fourth and sixth ECT sessions, with further cortisol reduction upon additional ECT.
• All patients who normalized their DSTs experienced progressive clinical improvement.

Conclusions:

• Serial DSTs can effectively monitor clinical response in major depressive disorder patients treated with ECT.
• Early DST normalization appears to be a potential predictor of a favorable treatment response.
• DSTs provide valuable biological data for understanding and managing depression treatment.